2020-08-31-accounts - Advocacy For Neuroacanthocytosis Patients

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

				2020	2019
		Unrestricted	Restricted	Total	Total
		funds	funds	funds	funds
	Notes	£	£	£	£
INCOME AND ENDOWMENTS FROM
Donations and legacies		116,954	65,000	181,954	179,091
Othertrading activities	2	190	-	190	4,000
Total		117,144	65,000	182,144	183,091
EXPENDITURE ON
Charitable activities
Research Grants and Symposium payments		90,556	-	90,556	82,159
Other		4,692	5,000	9,692	5,060
Total		95,248	5,000	100,248	87,219
NET INCOME		21,896	60,000	81,896	95,872
RECONCILIATION OF FUNDS
Total funds brought forward		89,309	41,006	130,315	34,443
TOTAL FUNDS CARRIED FORWARD		111,205	101,006	212,211	130,315

				2020	2019
		Unrestricted	Restricted	Total	Total
		funds	funds	funds	funds
	Notes	£	£	£	£
CURRENT ASSETS
Debtors	6	41	-	41	41
Investments	7	-	100,000	100,000	-
Cash at bank		111,805	1,006	112,811	130,903
		111,846	101,006	212,852	130,944
CREDITORS
Amounts falling due within one year	8	(641)		(641)	(629)
NET CURRENT ASSETS		111,205	101,006	212,211	130,315
TOTAL ASSETS LESS CURRENT
LIABILITIES		111,205	101,006	212,211	130,315
NET ASSETS		111,205	101,006	212,211	130,315
FUNDS	9
Unrestricted funds				111,205	89,309
Restricted funds				101,006	41,006
TOTAL FUNDS				212,211	130,315

			2020	2019
Part	time	administration	1	1

COMPARATIVES FORTHE STATEMENT OF FINANCIAL ACTIVITIES	COMPARATIVES FORTHE STATEMENT OF FINANCIAL ACTIVITIES	COMPARATIVES FORTHE STATEMENT OF FINANCIAL ACTIVITIES
	Unrestricted	Restricted	Total
	funds	funds	funds
	£	£	£
INCOME AND ENDOWMENTS FROM
Donations and legacies	138,735	40,356	179,091
Othertrading activities	4,000	-	4,000
Total	142,735	40,356	183,091
EXPENDITURE ON
Charitable activities
Research Grants and Symposium
payments	82,159	-	82,159
Other	5,060	-	5,060
Total	87,219	-	87,219
NET INCOME	55,516	40,356	95,872

5.	COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued	COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued	COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued	COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued
		Unrestricted	Restricted	Total
		funds	funds	funds
		£	£	£
	RECONCILIATION OF FUNDS
	Total funds broughtforward	33,793	650	34,443
	TOTAL FUNDS CARRIED
	FORWARD	89,309	41,006	130,315
6.	DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
			2020	2019
			£	£
	Other debtors		41	41
7.	CURRENT ASSET INVESTMENTS
			2020	2019
			£	£
	Rathbones		100,000
8.	CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
			2020	2019
			£	£
	Other creditors		641	629
9.	MOVEMENT IN FUNDS
			Net
			movement	At
		At 1.9.19	infunds	31.8.20
		£	£	£
	Unrestricted funds
	Undesignated Funds	89,309	21,896	111,205
	Restricted funds
	Harvard Donation	650	-	650
	Glenn Irvine Prize Fund	40,356	60,000	100,356
		41,006	60,000	101,006
	TOTAL FUNDS	130,315	81,896	212,211

Net movement in funds, included in the above are as	follows:
	Incoming	Resources	Movement
	resources	expended	in funds
	£	£	£
Unrestrictedfunds
Undesignated Funds	117,144	(95,248)	21,896
Restricted funds
Glenn Irvine Prize Fund	65,000	(5,000)	60,000
TOTAL FUNDS	182,144	(100,248)	81,896
Comparatives for movement in funds
		Net
		movement	At
	Atl.9.18	infunds	318.19
	£	£	£
Unrestricted funds
Undesignated Funds	33,793	55,516	89,309
Restricted funds
Harvard Donation	650	-	650
Glenn Irvine Prize Fund		40,356	40,356
	650	40,356	41,006
TOTAL FUNDS	34,443	95,872	130,315
Comparative net movement in funds, included inthe	above are as follows:
	Incoming	Resources	Movement
	resources	expended	in funds
	£	£	£
Unrestrictedfunds
Undesignated Funds	142,735	(87,219)	55,516
Restricted funds
Glenn Irvine Prize Fund	40,356	-	40,356
TOTAL FUNDS	183,091	(87,219)	95,872